SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 91.30 |
| Enterprise Value ($M) | -26.03 |
| Book Value ($M) | n/a |
| Book Value / Share | 2.64 |
| Price / Book | 0.72 |
| NCAV ($M) | 106.83 |
| NCAV / Share | 2.21 |
| Price / NCAV | 0.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.57 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.93 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.08 |
| Current Ratio | 9.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 120.15 |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | n/a |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | n/a |
| Cash from Investing | n/a |
| Cash from Financing | n/a |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nachtrab Matthew | 4.70 | -12.81 | |
| 13G/A | Barbier Remi | 4.20 | -17.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 378,770 | 996,683 | 38.00 | |
| 317,077 | 915,678 | 34.63 | |
| 273,959 | 965,059 | 28.39 | |
| 311,195 | 1,088,012 | 28.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RVPH – Reviva Pharmaceuticals Holdings, Inc. | RZLT – Rezolute, Inc. |
| SABS – SAB Biotherapeutics, Inc. | SBFM – Sunshine Biopharma, Inc. |
| SCLX – Scilex Holding Company |